Schedule Update - effective 1 June 2010 (text extract)

This is the text extract for Schedule Update - effective 1 June 2010, browse documents here.

Contents

Summary of PHARMAC decisions effective 1 June 2010 ................................ 3 Exceptional Circumstances prescription claiming .......................................... 4 Tramadol hydrochloride – new listing ........................................................... 5 Mitomycin C 5 mg injection – new listing ..................................................... 5 Deca-Durabolin Orgaject – new listing .......................................................... 6 Risperidone – reference pricing ..................................................................... 6 Losec Hp7 OAC discontinuation .................................................................... 7 News in brief ................................................................................................. 7 Named Specialists for antiretrovirals ............................................................. 8 Tender News .................................................................................................. 9 Looking Forward ........................................................................................... 9 Sole Subsidised Supply products cumulative to June 2010 ......................... 10 New Listings ................................................................................................ 19 Changes to Restrictions ............................................................................... 20 Changes to Subsidy and Manufacturer’s Price............................................. 26 Changes to Brand Name ............................................................................. 28 Changes to Sole Subsidised Supply ............................................................. 28 Delisted Items ............................................................................................. 29 Items to be Delisted .................................................................................... 31 Section H changes to Part II ........................................................................ 34 Section H changes to Part IV ....................................................................... 38 Index ........................................................................................................... 39

Summary of PharmaC decisions

effeCtIve 1 juNe 2010 New listings (page 19) • Enalapril (Arrow-Enalapril) tab 5 mg, 10 mg and 20 mg • Nandrolone decanoate (Deca-Durabolin Orgaject) inj 50 mg per ml, 1 ml – Retail pharmacy–Specialist – Section 29 • Tramadol hydrochloride (Arrow-Tramadol) cap 50 mg • Cytarabine (Pfizer) inj 500 mg and 1 g – PCT – Retail pharmacy–Specialist • Cytarabine (Pfizer) inj 2 g – PCT only – Specialist • Irinotecan (Irinotecan-Rex) inj 20 mg per ml, 2 ml and 5 ml – PCT only – Specialist – Special Authority • Mitomycin C (Arrow) inj 5 mg – PCT only – Specialist – Section 29 Changes to restrictions (pages 20-23) • Pancreatic enzyme (Cotazym ECS, Creon 10000, Creon Forte, Panzytrat) cap – removal of Retail pharmacy–Specialist restriction • Ferrous sulphate (Ferodan) oral liq 30 mg per 1 ml (6 mg elemental per 1 ml) – amended presentation • Malathion (Derbac-M) liq 0.5% – addition of Original Pack (OP) status • Combined oral contraceptives – removal of delisted brand names in Special Authority criteria • Progesterone-only contraceptives – removal of delisted brand names in Special Authority criteria • Alendronate for osteoporosis – amended Special Authority criteria • Naltrexone hydrochloride (ReVia) tab 50 mg – amended Special Authority criteria • Cytarabine (Pfizer, Mayne) inj 500 mg, 1 g and 2 g – amended presentation • Cytarabine (Baxter) inj 1 mg for ECP – amended of unit of measure Decreased subsidy (page 26) • Docusate sodium (Coloxyl) tab 50 mg and 120 mg • Risperidone (Ridal) tab 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg • Cytarabine (Pfizer) inj 100 mg • Vincristine sulphate inj 1 mg per ml, 2 ml (Hospira) and inj 1 mg for ECP (Baxter) Increased subsidy (page 26) • Cytarabine (Baxter) inj 1 mg for ECP • Vincristine sulphate (Hospira) inj 1 mg per ml, 1 ml

4 Pharmaceutical Schedule - Update News

Exceptional Circumstances prescription claiming

Exceptional Circumstances offers people funding for medicines that aren’t otherwise funded through the Pharmaceutical Schedule, or through DHB Hospitals. Once approved, Community Exceptional Circumstances (EC) approvals provide a subsidy sufficient to fully fund the pharmaceutical for that specific patient at a nominated pharmacy. Only that nominated pharmacy may claim a subsidy via an EC approval number. There are two types of EC approvals: • medicines not listed on the Pharmaceutical Schedule (e.g. propylthiouracil) • medicines listed on the Pharmaceutical Schedule where the patient does not meet the subsidy restrictions (e.g. imatinib mesylate for indications other than CML or GIST). EC Approval letters always state the nominated pharmacy and give a detailed description of the pharmaceutical(s) approved. This includes the Pharmacode numbers that may be claimed. If the Pharmacode number differs, pharmacists should contact the Exceptional Circumstances Panel Co-ordinator at PHARMAC prior to any dispensing, so that any related claim made by the pharmacy is not rejected. The Pharmacy Services Agreement gives details on how these EC prescriptions should be claimed. A description of this is

detailed below. However, if your pharmacy is the nominated pharmacy, you should review your own Pharmacy Services Agreement for completeness. For pharmaceuticals listed in the Pharmaceutical Schedule: • You will be paid the cost of the pharmaceutical as listed in the Pharmaceutical Schedule plus the usual margin towards procurement and stockholding costs. These are 4% for pharmaceuticals with a Pharmaceutical Schedule pack subsidy of less than $150.00, or 5% for pharmaceuticals with a Pharmaceutical Schedule pack subsidy that is equal to or greater than $150.00 and for all Special Foods. • Cost Brand Source Supply (CBS) should not be used for claims for EC pharmaceuticals listed in the Pharmaceutical Schedule. • A multiplier of 1.0 of the Base Pharmacy Service Fee (dispensing fee). • GST will be included in the calculation for payment.

Pharmaceutical Schedule - Update News

• The amount paid will be less the patient copayment contribution. For pharmaceuticals NOT listed in the Pharmaceutical Schedule: • You will be paid the cost of the Exceptional Circumstances Product – the GST exclusive invoice price to pharmacy of the minimum purchase order of the pharmaceutical required to satisfy the requirements of the pharmaceutical as at the date of dispensing. In this case pharmacists should annotate the

prescription as Cost Brand Source Supply (CBS) or attach a copy of the invoice. All receipts of purchase must be kept for audit purposes.. • A multiplier of 1.5 of the Base Pharmacy Service Fee (dispensing fee) • GST will be included in the calculation for payment. • The amount paid will be less the patient copayment contribution.

Tramadol hydrochloride – new listing

From 1 June 2010 Arrow-Tramadol (tramadol hydrochloride) 50 mg capsules will be subsidised without restriction on the Pharmaceutical Schedule. This treatment for acute and chronic pain will help fill an identified unmet clinical need in patients who cannot take currently funded alternatives.

Mitomycin C 5 mg injection – new listing

The Arrow brand of mitomycin C 5 mg injection will be subsidised from 1 June 2010. However, supplies of this brand will not be available until the middle of June. PHARMAC is listing this product from the beginning of the month so that DHB Hospital Pharmacies will be able to claim this product as soon as supplies are available. Mitomycin C 5 mg injection will be subsidised under the PCT only – Specialist restriction. This Arrow brand is also being supplied under Section 29 of the Medicines Act 1981 as it is an unapproved medicine.

6 Pharmaceutical Schedule - Update News

Deca-Durabolin Orgaject – new listing

Due to an out-of-stock situation, the Australian brand of Deca-Durabolin Orgaject (nandrolone deconoate) 50 mg per ml 1 ml injection will be subsidised from 1 June 2010. The Retail pharmacy-Specialist restriction will apply to this formulation also. The Australian brand of Deca-Durabolin Orgaject is an unapproved medicine and is being supplied under Section 29 of the Medicines Act 1981.

Risperidone – reference pricing

PHARMAC has decided to apply reference pricing across different brands of risperidone from 1 June 2010, where such reference pricing is possible in light of the contractual arrangements PHARMAC has with the different suppliers. The effect of the decision is that from 1 June 2010 the subsidy for the Ridal brand of risperidone tablets will be reduced in Section B of the Pharmaceutical Schedule to the level of the subsidy for Apo-Risperidone tablets and Dr Reddy’s Risperidone tablets. Douglas Pharmaceuticals Ltd has notified PHARMAC that it has reduced its price to match the subsidy for Ridal tablets so they will remain fully subsidised at the lower price. All other currently funded brands of risperidone tablets (Apo-Risperidone, Dr Reddy’s Risperidone and Risperdal) will remain fully funded. We note that Risperdal tablets (supplied by JanssenCilag) have protection from subsidy reduction until 1 July 2012; therefore, no changes to the subsidy for Risperdal tablets could occur before 1 July 2012 without the supplier’s agreement.

Pharmaceutical Schedule - Update News

Losec Hp7 OAC discontinuation

PHARMAC has received notice from AstraZeneca that it intends to discontinue its omeprazole, amoxicillin and clarithromycin combination pack (Losec Hp7 OAC) that is used for the treatment of helicobacter pylori eradication. The individual components are available fully funded as an alternative to this combination pack. Losec Hp7 OAC will be delisted from 1 December 2010.

News in brief:

• Malathion 0.5% liquid (Derbac-M) will be able to be claimed as original packs (OP’s) from 1 June 2010. • The Special Authority for subsidy for alendronate sodium with or without cholecalciferol tablets (Fosamax and Fosamax Plus) will be amended from 1 June 2010. The amendment is to the Note only and not the access criteria. The change would clarify that it is the BMD measurements (which are used to derive T-Scores) that must be made using DXA. • Last month we amended the line item descriptions for mineral products listed in the Pharmaceutical Schedule to include the elemental content. We made an error in the listing for ferrous sulphate oral liquid. This has now been corrected. • The cytarabine (Baxter) injection for ECP pack size has been amended from 1 mg to 10 mg from 1 June 2010. A new pharmacode (2359413) has been issued for this new pack size.

8 Pharmaceutical Schedule - Update News

Named Specialists for antiretrovirals

Below is a list of currently approved named Specialists that the Ministry of Health has approved to prescribe HIV antiretroviral agents in New Zealand Auckland Dr Emma Best Dr Simon Briggs Dr Rod Ellis-Pegler Dr Rick Franklin Dr Rupert Handy Dr David Holland Dr Joan Ingram Prof. Diana Lennon Dr Mitzi Nisbet Dr Nicky Perkins Dr Stephen Ritchie Dr Sally Roberts Dr Simon Rowley Dr Mark Thomas Dr Leslie Voss Dr Liz Wilson Hamilton Dr Graeme Mills Dr Jane Morgan Tauranga Dr Anthony Graham Dr Katherine Grimwade Dr Elizabeth Spellacy Napier Dr Andrew Burns Dr Richard Meech Palmerston North Dr Anne Robertson Wellington Dr Tim Blackmore Dr Kenneth Romeril Dr Nigel Raymond Dr Richard Steele Nelson Dr Stephen Delany Dr Richard Everts Christchurch Dr Stephen Chambers Dr Robin Corbett Dr Sarah Metcalf Dr Maud Meates-Dennis Dr Alan Pithie Dunedin Dr Charles Beresford Dr Geoffery Clover Dr Igor Melnychuk Dr Deborah Williams

tender News

Sole Subsidised Supply changes – effective 1 July 2010

Chemical Name Dihydrocodeine tartrate Docusate sodium with sennosides Hydroxocobalamin Letrozole Promethazine hydrochloride Somatropin Somatropin Tranexamic acid Zidovudine [AZT] Zidovudine [AZT] Presentation; Pack size Tab long-acting 60 mg; 60 tab Tab 50 mg with total sennosides 8 mg; 200 tab Inj 1 mg per ml, 1 ml; 3 amp Tab 2.5 mg, 30 tab Oral liq 5 mg per 5 ml; 100 ml Inj cartridge 16 iu (5.3 mg); 5 vial Inj cartridge 36 iu (12 mg); 5 vial Tab 500 mg; 100 tab Cap 100 mg; 100 cap Oral liq 10 mg per ml; 200 ml OP Sole Subsidised Supply brand (and supplier) DHC Continus (MundiPharma) Laxsol (Sigma) ABM Hydroxocobalamin (ABM) Letara (Douglas) Promethazine Winthrop Elixir (Sanofi-Aventis) Genotropin (Pfizer) Genotropin (Pfizer) Cyklokapron (Pfizer) Retrovir (GSK) Retrovir (GSK)

Looking forward

This section is designed to alert both pharmacists and prescribers to possible future changes to the Pharmaceutical Schedule. It may also assist pharmacists, distributors and wholesalers to manage stock levels. Decision for implementation 1 july 2010 • Antiretrovirals – amended Special Authority criteria • Domperidone (Motilium) tab 10 mg – subsidy increase to match price and removal of Special Authority for Manufacturers Price • Hormone replacement therapy – Systemic – amended Special Authority criteria • Metoprolol succinate (AFT-Metoprolol CR and Betaloc CR) tab long-acting 23.75 mg, 47.5 mg, 95 mg and 190 mg – subsidy decrease • Octreotide inj 50 μg per ml, 1 ml, inj 100 μg per ml, 1 ml, inj 500 μg per ml, 1 ml, inj LAR 10 mg prefilled syringe, inj LAR 20 mg prefilled syringe and inj LAR 30 mg prefilled syringe – amended Special Authority • Potassium iodate (NeuroKare) tab 150 μg – new listing • Tolcapone (Tasmar) tab 100 mg – removal of Retail pharmacy-Specialist prescription, Specialist must be a neurologist, geriatrician or general physician • Tretinoin (ReTrieve) crm 0.5 mg/g – new listing with maximum of 50 g per prescription

Sole Subsidised Supply Products – cumulative to June 2010

Generic Name

Acarbose Acetazolamide Allopurinol Alprazolam Amantadine hydrochloride Amlodipine Amoxycillin

Presentation

Tab 50 mg & 100 mg Tab 250 mg Tab 100 mg & 300 mg Tab 250 µg, 500 µg & 1 mg Cap 100 mg Tab 5 mg & 10 mg Grans for oral liq 250 mg per 5 ml Drops 125 mg per 1.25 ml Inj 250 mg, 500 mg & 1 g Cap 250 mg & 500 mg

Brand Name Expiry Date*

Glucobay Diamox Apo-Allopurinol Arrow-Alprazolam Symmetrel Apo-Amlodipine Ospamox Ospamox Paediatric Drops Ibiamox Apo-Amoxi Curam Curam Synermox AFT Ethics Aspirin Ethics Aspirin EC Pacific Atenolol AstraZeneca Arrow-Azithromycin Pacifen Sandoz Beta Scalp Fibalip Bicalox Lax-Tabs AFT Marcain Isobaric Marcain Heavy healthE API Miacalcic Airflow Calsource 2011 2011 2010 2012 2012 2012 2012 2011 2012 2011 2011 2010 2011 2010 2012 2011 2012 2011 2012 2011 2011 2010 2011 2011 2012 2011 2010 2012

Amoxycillin clavulanate

Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml Grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml Tab amoxycillin 500 mg with potassium clavulanate 125 mg Crm 500 g Tab dispersible 300 mg Tab 100 mg Tab 50 mg & 100 mg Inj 600 µg, 1 ml Tab 500 mg Tab 10 mg Inj 1 mega u Scalp app 0.1% Tab 200 mg Tab 50 mg Tab 5 mg Eye drops 0.2% Inj 0.5%, 4 ml Inj 0.5%, 8% glucose, 4 ml Crm, aqueous, BP Lotn, BP Inj 100 iu per ml, 1 ml Cap 0.25 µg & 0.5 µg Tab eff 1 g

Aqueous cream Aspirin Atenolol Atropine sulphate Azithromycin Baclofen Benzylpenicillin sodium (Penicillin G) Betamethasone valerate Bezafibrate Bicalutamide Bisacodyl Brimonidine tartrate Bupivicaine hydrochloride Calamine Calcitonin Calcitriol Calcium

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

Sole Subsidised Supply Products – cumulative to June 2010

Generic Name

Calcium folinate Captopril Cefaclor monohydrate Cefazolin sodium Cefuroxime sodium Cephalexin monohydrate Cetomacrogol Cetirizine hydrochloride Chloramphenicol Chlorhexidine gluconate Ciclopiroxolamine Ciprofloxacin Citalopram Clarithromycin Clobetasol propionate

Presentation

Inj 50 mg Tab 12.5 mg, 25 mg & 50 mg Cap 250 mg Grans for oral liq 125 mg per 5 ml Inj 500 mg & 1 g Inj 750 mg & 1.5 g Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Crm BP Tab 10 mg Oral liq 1 mg per ml Eye oint 1% Soln 4% Nail soln 8% Tab 250 mg, 500 mg & 750 mg Tab 20 mg Tab 250 mg Grans for oral liq 125 mg per 5 ml Crm 0.05% Oint 0.05% Scalp app 0.05% Tab 500 µg & 2 mg TDDS 2.5 mg, 100 µg per day TDDS 5 mg, 200 µg per day TDDS 7.5 mg, 300 µg per day Inj 150 µg per ml, 1 ml Tab 25 µg Tab 150 µg Crm 1% Vaginal crm 1% with applicator(s) Vaginal crm 2% with applicators(s) Tab 15 mg, 30 mg & 60 mg Tab 500 µg Sach 5 g Inj 150 mg Powder for soln for oral use Tab 50 mg Tab 50 mg

Brand Name Expiry Date*

Calcium Folinate Ebewe Apo-Captopril Ranbaxy-Cefaclor Ranbaxy-Cefaclor Hospira Zinacef Cefalexin Sandoz Cefalexin Sandoz PSM Zetop Cetirizine-AFT Chlorsig Orion Batrafen Rex Medical Arrow-Citalopram Klamycin Klacid Dermol Dermol Dermol Paxam Catapres-TTS-1 Catapres-TTS-2 Catapres-TTS-3 Catapres Dixarit Catapres Clomazol Clomazol Clomazol PSM Colgout Colestid Colistin-Link Enerlyte Nausicalm Cycloblastin 2011 2010 2010 2011 2011 2012 2010 2011 2012 2011 2012 2011 2011 2010 2012

Clonazepam Clonidine

2011 2012

Clonidine hydrochloride

2012

Clotrimazole

2011 2010 2010 2010 2010 2010 2010 2012 2010

Codeine phosphate Colchicine Colestipol hydrochloride Colistin sulphomethate Compound electrolytes Cyclizine hydrochloride Cyclophosphamide

Sole Subsidised Supply Products – cumulative to June 2010

Generic Name

Cyproterone acetate Cyproterone acetate with ethinyloestradiol Desferrioxamine mesylate Desmopressin Dexamphetamine sulphate Dextrose Dextrose with electrolytes

Presentation

Tab 50 mg & 100 mg Tab 2 mg with ethinyloestradiol 35 µg and 7 inert tabs Inj 500 mg Nasal spray 10 µg per dose Tab 5 mg Inj 50%, 10 ml Oral soln with electrolytes

Brand Name Expiry Date*

Siterone Ginet 84 Mayne Desmopressin-PH&T PSM Biomed Pedialyte – Plain Pedialyte – Bubblegum Pedialyte – Fruit Diclofenac Sandoz Voltaren Ophtha Voltaren Voltaren Dilzem Cardizem CD Pytazen SR Apo-Doxazosin AFT Clexane Comtan E-Mycin E-Mycin E-Mycin NZ Medical and Scientific Brevinor 21 Brevinor 1/21 Brevinor 1/28 Arrow-Etidronate Felo 5 ER Felo 10 ER Ferodan Fintral 2012 2012 2010 2011 2012 2011 2010 2011 2010 2011 2010

Diclofenac sodium

Tab EC 25 mg & 50 mg Eye drops 1 mg per ml Inj 25 mg per ml, 3 ml Suppos 12.5 mg, 25 mg, 50 mg & 100 mg Tab 30 mg & 60 mg Cap long-acting 120 mg, 180 mg & 240 mg Tab long-acting 150 mg Tab 2 mg & 4 mg Oint BP Inj 20 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg & 150 mg Tab 200 mg Tab 400 mg Grans for oral liq 200 mg per 5 ml Grans for oral liq 400 mg per 5 ml Tab 10 µg Tab 35 µg with norethisterone 500 µg Tab 35 µg with norethisterone 1 mg Tab 35 µg with norethisterone 1 mg and 7 inert tab Tab 200 mg Tab long-acting 5 mg Tab long-acting 10 mg Oral liq 150 mg per 5 ml Tab 5 mg

2012 2011

Diltiazem hydrochloride

2011

Dipyridamole Doxazosin mesylate Emulsifying ointment Enoxaparin sodium (low molecular weight heparin) Entacapone Erythromycin ethyl succinate

2011 2010 2011 2012 2012 2012 2011 2012 2010

Ethinyloestradiol Ethinyloestradiol with norethisterone

Etidronate disodium Felodipine Ferrous sulphate Finasteride

Sole Subsidised Supply Products – cumulative to June 2010

Generic Name

Flucloxacillin sodium

Presentation

Cap 250 mg & 500 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Inj 250 mg, 500 mg & 1 g Cap 50 mg, 150 mg & 200 mg Inj 50 mg Tab 10 mg Oint 950 µg, with fluocortolone pivalate 920 µg, and cinchocaine hydrochloride 5 mg per g Suppos 630 µg, with fluocortolone pivalate 610 µg, and cinchocaine hydrochloride 1 mg Eye drops 0.1% Cap 20 mg Tab disp 20 mg, scored Metered aqueous nasal spray, 50 µg per dose Tab 40 mg Crm 2% Oint 2% Cap 100 mg, 300 mg & 400 mg Inj 40 mg per ml, 2 ml Tab 80 mg Tab 5 mg Tab 600 µg Oral pump spray 400 µg per dose TDDS 5 mg & 10 mg

Brand Name Expiry Date*

AFT AFT AFT Flucloxin Pacific Fludara Fludara Oral Ultraproct Ultraproct 2012 2011 2011 2011 2010

Fluconazole Fludarabine phosphate Fluocortolone caproate with fluocortolone pivalate and cinchocaine

Fluorometholone Fluoxetine hydrochloride Fluticasone propionate Furosemide Fusidic acid Gabapentin Gentamicin sulphate Gliclazide Glipizide Glyceryl trinitrate

FML Fluox Fluox Flixonase Hayfever & Allergy Diurin 40 Foban Foban Nupentin Pfizer Apo-Gliclazide Minidiab Lycinate Nitrolingual Pumpspray Nitroderm TTS Serenace Serenace Douglas ABM PSM Colifoam Locoid DP Lotn HC Plaquenil Methopt

2012 2010 31/1/13 2012 2010 31/7/12 2012 2011 2011 2011

Haloperidol Hydrocortisone

Oral liq 2 mg per ml Tab 500 µg, 1.5 mg & 5 mg Tab 5 mg & 20 mg Powder Crm 1% Rectal foam 10%, CFC-free (14 applications) Scalp lotn 0.1% Lotn 1% with wool fat hydrous 3% and mineral oil Tab 200 mg Eye drops 0.5%

2010 2012 2011 2012 2010 2011 2012 2011

Hydrocortisone acetate Hydrocortisone butyrate Hydrocortisone with wool fat and mineral oil Hydroxychloroquine sulphate Hypromellose

Sole Subsidised Supply Products – cumulative to June 2010

Generic Name

Hysocine N-butylbromide Ibuprofen Ipratropium bromide

Presentation

Inj 20 mg, 1 ml Tab 20 mg Tab 200 mg Oral liq 100 mg per 5 ml Aqueous nasal spray, 0.03% Nebuliser soln, 250 µg per ml, 1 ml Nebuliser soln, 250 µg per ml, 2 ml Inj 50 mg per ml, 2 ml Cap 10 mg & 20 mg Cap 100 mg Shampoo 2% Oral liq 10 g per 15 ml Eye drops 50 µg per ml Eye drops 0.25% & 0.5% Inj 0.5%, 5 ml Inj 1%, 5 ml Inj 1%, 20 ml Crm 2.5% with prilocaine 2.5%; 30 g OP Crm 2.5% with prilocaine 2.5%; 5 g Tab 5 mg, 10 mg & 20 mg Tab 2 mg Tab 10 mg Oral liq 1 mg per ml

Brand Name Expiry Date*

Buscopan Gastrosoothe Ethics Ibuprofen Fenpaed Apo-Ipravent Ipratripium Steri-Neb Ipratripium Steri-Neb Ferrum H Oratane Sporanox Sebizole Duphalac Hysite Betagan Xylocaine Xylocaine Xylocaine EMLA EMLA Arrow-Lisinopril Nodia Loraclear Hayfever Relief Lorapaed Derbac M A-Lices Foremount Child’s Silicone Mask De-Worm Colofac Provera Pentasa Apotex Biodone Biodone Forte Biodone Extra Forte Methatabs 2012 2010 2010 2011 2012 2010 2010

Iron polymaltose Isotretinoin Itraconazole Ketoconazole Lactulose Latanoprost Levobunolol Lignocaine hydrochloride

2011 2012 2010 2011 2010 2012 2010 2010

Lignocaine with prilocaine

2010

Lisinopril Loperamide hydrochloride Loratadine

Malathion Mask for Spacer Device Mebendazole Mebeverine hydrochloride Medroxyprogesterone acetate Mesalazine Metformin hydrochloride Methadone hydrochloride

Liq 0.5% Shampoo 1% Device Tab 100 mg Tab 135 mg Tab 2.5 mg, 5 mg, 10 mg, 100 mg & 200 mg Enema 1 g per 100 ml Tab immediate-release 500 mg & 850 mg Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Tab 5 mg

2010 2011 30/9/11 2011 2011 2010 2012 2012 2012 2010

Sole Subsidised Supply Products – cumulative to June 2010

Generic Name

Methotrexate

Presentation

Tab 2.5 mg & 10 mg Inj 100 mg per ml, 10 ml Inj 100 mg per ml, 50 ml Tab 125 mg, 250 mg & 500 mg Tab 4 mg & 100 mg Inj 40 mg per ml, 1 ml Inj 40 mg per ml with lignocaine 1 ml Inj 40 mg per ml, 1 ml Inj 62.5 mg per ml, 2 ml Inj 500 mg Inj 1 g Inj 5 mg per ml, 2 ml Crm 2% Crm 0.1% Oint 0.1% Oral liq 1 mg per ml Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Tab immediate release 10 mg & 20 mg Inj 10 mg per ml, 1 ml Inj 30 mg per ml, 1 ml Tab 40 mg & 80 mg Tab 50 mg Tab 250 mg Tab 500 mg Tab 275 mg Inj 2.5 mg per ml, 1 ml Oral suspension 10 mg per ml Tab 200 mg

Brand Name Expiry Date*

Methoblastin Methotrexate Ebewe Methotrexate Ebewe Prodopa Medrol Depo-Medrol Depo-Medrol with Lidocaine Solu-Medrol Solu-Medrol Solu-Medrol Solu-Medrol Pfizer Multichem m-Mometasone m-Mometasone RA-Morph RA-Morph RA-Morph RA-Morph Sevredol Mayne Mayne Apo-Nadolol ReVia Noflam 250 Noflam 500 Sonaflam AstraZeneca Viramune Suspension Viramune Habitrol Habitrol Habitrol Habitrol Noriday 28 Primolut N Norpress 2012 2011 2011 2012 2011 2011 2012

Methyldopa Methylprednisolone Methylprednisolone acetate Methylprednisolone acetate with lignocaine Methylprednisolone sodium succinate

Metoclopramide hydrochloride Miconazole nitrate Mometasone furoate Morphine hydrochloride

2011 2011 2012 2012

Morphine sulphate

2012 2011 2010 2010 2012 2010 2010 2012

Nadolol Naltrexone hydrochloride Naproxen Naproxen sodium Neostigmine Nevirapine

Nicotine

Patch 7 mg, 14 mg & 21 mg Lozenge 1 mg & 2 mg Gum 2 mg & 4 mg (Fruit) Gum 2 mg & 4 mg (Mint) Tab 350 µg Tab 5 mg Tab 10 mg & 25 mg

2010

Norethisterone Nortriptyline hydrochloride

2012 2011 2011

Sole Subsidised Supply Products – cumulative to June 2010

Generic Name

Nystatin

Presentation

Oral liq 100,000 u per ml, 24 ml OP Cap 500,000 u Tab 500,000 u Cap 10 mg, 20 mg & 40 mg Inj 40 mg

Brand Name Expiry Date*

Nilstat Nilstat Nilstat Dr Reddy’s Omeprazole Dr Reddy’s Omeprazole Zofran Zofran Zydis Apo-Oxybutynin Apo-Oxybutynin OxyNorm OxyNorm Syntocinon Syntocinon Syntometrine Pamisol Pamisol Pamisol Pantocid IV Dr Reddy’s Pantoprazole Pharmacare Paracare Junior Paracare Double Strength ParaCode Lacri-Lube Loxamine Breath-Alert Pegasys Pegasys Pegasys RBV Combination Pack Pegasys RBV Combination Pack Pegasys RBV Combination Pack Pegasys RBV Combination Pack Permax A-Scabies 2011 2010 2011

Omeprazole

Ondansetron Oxybutynin Oxycodone hydrochloride Oxytocin

Tab 4 mg & 8 mg Tab disp 4 mg & 8 mg Tab 5 mg Oral liq 5 mg per 5 ml Inj 10 mg per ml, 1 ml & 2 ml Oral liq 5 mg per 5 ml Inj 5 iu per ml, 1 ml Inj 10 iu per ml, 1 ml Inj 5 iu with ergometrine maleate 500 µg per ml, 1 ml Inj 3 mg per ml, 5 ml Inj 3 mg per ml, 10 ml Inj 6 mg per ml, 10 ml Inj 40 mg Tab 20 mg & 40 mg Tab 500 mg Oral liq 120 mg per 5 ml Oral liq 250 mg per 5 ml Tab paracetamol 500 mg with codeine phosphate 8 mg Eye oint with soft white paraffin Tab 20 mg Low range and Normal range Inj 135 µg prefilled syringe Inj 180 µg prefilled syringe Inj 135 µg prefilled syringe x 4 with ribavirin tab 200 mg x 112 Inj 135 µg prefilled syringe x 4 with ribavirin tab 200 mg x 168 Inj 180 µg prefilled syringe x 4 with ribavirin tab 200 mg x 112 Inj 180 µg prefilled syringe x 4 with ribavirin tab 200 mg x 168 Tab 0.25 mg & 1 mg Lotn 5%

2010 2010 2010 2012

Pamidronate disodium

2011

Pantoprazole

2010

Paracetamol

2011

Paracetamol with codeine Paraffin liquid with soft white paraffin Paroxetine hydrochloride Peak Flow Meter Pegylated interferon alpha-2A

2012 2010 2010 30/9/11 31/12/12

Pergolide Permethrin

2011 2011

Sole Subsidised Supply Products – cumulative to June 2010

Generic Name

Phenoxymethylpenicillin (Penicillin V) Phenylephrine hydrochloride Pindolol Pioglitazone Pizotifen Poloxamer Polyvinyl alcohol Potassium chloride Prazosin hydrochloride Prednisone Prednisone sodium phosphate Procaine penicillin Promethazine hydrochloride Quinapril Quinapril with hydroclorothiazide

Presentation

Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap potassium salt 250 mg & 500 mg Eye drops 0.12% Tab 5 mg, 10 mg & 15 mg Tab 15 mg, 30 mg & 45 mg Tab 500 µg Oral drops 10% Eye drops 1.4% Eye drops 3% Tab long-acting 600 mg Tab 1 mg, 2 mg & 5 mg Tab 1 mg, 2.5 mg, 5 mg & 20 mg Oral liq 5 mg per ml Inj 1.5 mega u Tab 10 mg & 25 mg Tab 5 mg, 10 mg & 20 mg Tab 10 mg with hydroclorothiazide 12.5 mg Tab 20 mg with hydroclorothiazide 12.5 mg Tab 300 mg Oral liq 150 mg per 10 ml Cap 150 mg Tab 0.25 mg, 1 mg, 2 mg and 5 mg Tab 150 mg & 300 mg Nebuliser soln, 1 mg per ml, 2.5 ml Nebuliser soln, 2 mg per ml, 2.5 ml Oral liq 2 mg per 5 ml Nebuliser soln, 2.5 mg with ipratopium bromide 0.5 mg per vial, 2.5 ml Tab 5 mg Tab 10 mg Tab 20 mg Tab 40 mg Tab 80 mg Grans eff 4 g sachets Nasal spray, 4%

Brand Name Expiry Date*

AFT AFT Cilicaine VK Prefrin Apo-Pindolol Pizaccord Sandomigran Coloxyl Vistil Vistil Forte Span-K Apo-Prazo Apo-Prednisone Redipred Cilicaine Allersoothe Accupril Accuretic 10 Accuretic 20 Q 300 Peptisoothe Mycobutin Ropin ArrowRoxithromycin Asthalin Asthalin Salapin Duolin 2012 2010 2010 2010 2012 2012 2010 2012 2010

2010 2012 2012 2012 2011 2011 2012 2010 2011 2012 2011 2011 2011 2011

Quinine sulphate Ranitidine hydrochloride Rifabutin Ropinirole hydrochloride Roxithromycin Salbutamol

Salbutamol with ipratropium bromide Selegiline hydrochloride Simvastatin

Apo-Selegiline Arrow-Simva 10 mg Arrow-Simva 20 mg Arrow-Simva 40 mg Arrow-Simva 80 mg Ural Rex

2012 2011

Sodium citro-tartrate Sodium cromoglycate

2010 2012

Sole Subsidised Supply Products – cumulative to June 2010

Generic Name

Sotalol Spacer Device Sumatriptan Syrup (pharmaceutical grade) Tar with triethanolamine lauryl sulphate and fluorescein Temazepam Terazosin hydrochloride Terbinafine Testosterone cypionate Tetracosactrin Timolol maleate Triamcinolone acetonide

Presentation

Tab 80 mg & 160 mg 230 ml Tab 50 mg & 100 mg Liq Soln 2.3% Tab 10 mg Tab 2 mg & 5 mg Tab 250 mg Inj long-acting 100 mg per ml, 10 ml Inj 250 µg Inj 1 mg per ml, 1 ml Tab 10 mg Eye drops 0.25% & 0.5% Crm 0.02% Oint 0.02% Inj 40 mg per ml, 1 ml 0.1% in Dental Paste USP Tab 300 mg Cap 5 mg Cap 300 mg Inj 50 mg per ml, 10 ml Oint BP Cap 220 mg Tab 7.5 mg

Brand Name Expiry Date*

Mylan Space Chamber Arrow-Sumatriptan Midwest Pinetarsol Normison Apo-Terazosin Apo-Terbinafine Depo-Testosterone Synacthen Synacthen Depot Apo-Timol Apo-Timop Aristocort Aristocort Kenacort-A40 Oracort TMP Navoban Actigall Pacific PSM Zincaps Apo-Zopiclone 2012 30/9/11 2013 2010 2011 2011 2010 2011 2011 2011 2012 2011 2011

Trimethoprim Tropisetron Ursodeoxycholic acid Vancomycin hydrochloride Zinc and castor oil Zinc sulphate Zopiclone June changes in bold

2011 2012 2011 2011 2011 2011 2011

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings

Effective 1 June 2010

49 ENALAPRIL ❋ Tab 5 mg ................................................................................. 1.98 ❋ Tab 10 mg ............................................................................... 2.44 ❋ Tab 20 mg ............................................................................... 3.24 NANDROLONE DECANOATE – Retail pharmacy-Specialist Inj 50 mg per ml, 1 ml ............................................................ 21.16 TRAMADOL HYDROCHLORIDE Cap 50 mg ................................................................................ 6.95 CYTARABINE Inj 500 mg – PCT – Retail pharmacy-Specialist ....................... 18.15 Inj 1 g – PCT – Retail pharmacy-Specialist .............................. 37.00 Inj 2 g – PCT only – Specialist ................................................. 31.00 IRINOTECAN – PCT only – Specialist – Special Authority see SA0878 Inj 20 mg per ml, 2 ml ............................................................ 41.00 Inj 20 mg per ml, 5 ml .......................................................... 100.00 MITOMYCIN C – PCT only – Specialist Inj 5 mg ................................................................................. 72.75 90 90 90 1 ✔ Arrow-Enalapril ✔ Arrow-Enalapril ✔ Arrow-Enalapril ✔ Deca-Durabolin Orgaject S29 ✔ Arrow-Tramadol ✔ Pfizer ✔ Pfizer ✔ Pfizer ✔ Irinotecan-Rex ✔ Irinotecan-Rex ✔ Arrow S29

109 138

100 1 1 1 1 1 1

139

142

Effective 5 May 2010

100 DICLOFENAC SODIUM ❋ Tab EC 25 mg ........................................................................... 1.63 ❋ Tab EC 50 mg ........................................................................... 2.13 50 50 ✔ Diclofenac Sandoz ✔ Diclofenac Sandoz

Effective 1 May 2010

55 77 109 138 BENDROFLUAZIDE ❋ Tab 2.5 mg – Up to 150 tab available on a PSO ......................... 7.58 May be supplied on a PSO for reasons other than emergency. ❋ Tab 5 mg ............................................................................... 11.75 TESTOSTERONE UNDECANOATE – Retail pharmacy–Specialist Cap 40 mg .............................................................................. 79.92 LIGNOCAINE Gel 2%, 10 ml urethral syringe ................................................. 43.26 FLUOROURACIL SODIUM Inj 50 mg per ml, 10 ml – PCT only – Specialist ....................... 24.75 500 500 100 10 5 ✔ Arrow Bendrofluazide ✔ Arrow Bendrofluazide ✔ Arrow-Testosterone ✔ Pfizer ✔ Fluorouracil Ebewe

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions

Effective 1 June 2010

33 PANCREATIC ENZYME Cap 8,000 USP u lipase, 30,000 USP u amylase, 30,000 USP u protease – Retail pharmacy-Specialist ........... 85.00 Cap EC 10,000 BP u lipase, 9,000 BP u amylase and 210 BP u protease – Retail pharmacy-Specialist................... 34.93 Cap EC 25,000 BP u lipase, 18,000 BP u amylase, 1,000 BP u protease – Retail pharmacy-Specialist................ 94.38 Cap EC 25,000 BP u lipase, 22,500 BP u amylase, 1,250 BP u protease – Retail pharmacy-Specialist................ 94.40 FERROUS SULPHATE ❋‡ Oral liq 30 mg per 1 ml 150 mg per 5 ml (6 mg elemental per 1 ml 30 mg elemental per 1 ml) .............. 10.30 MALATHION Liq 0.5% ................................................................................... 4.99 250 100 100 100 ✔ Cotazym ECS ✔ Creon 10000 ✔ Creon Forte ✔ Panzytrat

500 ml

✔ Ferodan

65 71

200 ml OP ✔ Derbac-M

COMBINED ORAL CONTRACEPTIVES ➽ SA0500 Special Authority for Alternate Subsidy Initial application from any medical practitioner. Approvals valid for 2 years for applications meeting the following criteria: Both: 1 Either: 1.1 Patient is on a Social Welfare benefit; or 1.2 Patient has an income no greater than the benefit; and 2 Has tried at least one of the fully funded options and has been unable to tolerate it. Renewal from any medical practitioner. Approvals valid for 2 years for applications meeting the following criteria: Either: 1 Patient is on a Social Welfare benefit; or 2 Patient has an income no greater than the benefit. Notes: The approval numbers of Special Authorities approved after 1 November 1999 are interchangeable between Mercilon, and Marvelon, Minulet and Femodene. The additional subsidy will fund Mercilon, and Marvelon, Minulet and Femodene up to the manufacturer’s price for each of these products as identified on the Schedule at 1 November 1999. Special Authorities approved before 1 November 1999 remain valid until the expiry date and can be renewed providing that women are still either: • on a Social Welfare benefit; or • have an income no greater than the benefit. The approval numbers of Special Authorities approved before 1 November 1999 are interchangeable for products within the combined oral contraceptives and progestogen-only contraceptives groups, except Loette and Microgynon 20 ED

PROGESTOGEN-ONLY CONTRACEPTIVES ➽ SA0500 Special Authority for Alternate Subsidy Initial application from any medical practitioner. Approvals valid for 2 years for applications meeting the following criteria: Both: 1 Either: 1.1 Patient is on a Social Welfare benefit; or 1.2 Patient has an income no greater than the benefit; and continued... 2 Has tried at least one of the fully funded options and has been unable to tolerate it.

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 June 2010 (continued)

continued... Renewal from any medical practitioner. Approvals valid for 2 years for applications meeting the following criteria: Either: 1 Patient is on a Social Welfare benefit; or 2 Patient has an income no greater than the benefit. Notes: The approval numbers of Special Authorities approved after 1 November 1999 are interchangeable between Mercilon, and Marvelon, Minulet and Femodene. The additional subsidy will fund Mercilon, and Marvelon, Minulet and Femodene up to the manufacturer’s price for each of these products as identified on the Schedule at 1 November 1999. Special Authorities approved before 1 November 1999 remain valid until the expiry date and can be renewed providing that women are still either: • on a Social Welfare benefit; or • have an income no greater than the benefit. The approval numbers of Special Authorities approved before 1 November 1999 are interchangeable for products within the combined oral contraceptives and progestogen-only contraceptives groups, except Loette and Microgynon 20 ED ALENDRONATE SODIUM – Special Authority see SA0990 – Retail pharmacy Tab 70 mg ............................................................................. 35.91 4 ✔ Fosamax

107

ALENDRONATE SODIUM WITH CHOLECALCIFEROL – Special Authority see SA0990 – Retail pharmacy Tab 70 mg with cholecalciferol 5,600 iu .................................. 35.91 4 ✔ Fosamax Plus Tab 70 mg with cholecalciferol 2,800 iu .................................. 35.91 4 ✔ Fosamax Plus ➽ SA0990 Special Authority for Subsidy Initial application — (Underlying cause – Osteoporosis) from any relevant practitioner. Approvals valid without further renewal unless notified for applications meeting the following criteria: Any of the following: 1 History of one significant osteoporotic fracture demonstrated radiologically and documented bone mineral density (BMD) ≥ 2.5 standard deviations below the mean normal value in young adults (i.e. T-Score ≤ -2.5) (see Note); or 2 History of one significant osteoporotic fracture demonstrated radiologically, and either the patient is elderly, or densitometry scanning cannot be performed because of major logistical, technical or pathophysiological reasons. It is unlikely that this provision would apply to many patients under 75 years of age; or 3 History of two significant osteoporotic fractures demonstrated radiologically; or 4 Documented T-Score ≤ -3.0 (see Note); or 5 A 10-year risk of hip fracture ≥ 3%, calculated using a published risk assessment algorithm (e.g. FRAX or Dubbo) which incorporates BMD measurements (see Note). Initial application — (Underlying cause – glucocorticosteroid therapy) from any relevant practitioner. Approvals valid for 1 year for applications meeting the following criteria: Both: 1 The patient is receiving systemic glucocorticosteriod therapy (≥ 5 mg per day prednisone equivalents) and has already received or is expected to receive therapy for at least three months; and 2 Either: 2.1 The patient has documented BMD ≥ 1.5 standard deviations below the mean normal value in young adults (i.e. T-Score ≤ -1.5) (see Note); or 2.2 The patient has a history of one significant osteoporotic fracture demonstrated radiologically. Renewal — (Underlying cause was, and remains, glucocorticosteroid therapy) from any relevant practitioner. Approvals valid for 1 year where the patient is continuing systemic glucocorticosteriod therapy (≥ 5 mg per day prednisone equivalents). Renewal — (Underlying cause was glucocorticosteroid therapy but patient now meets the ’Underlying cause osteoporosis’ criteria) from any relevant practitioner. Approvals valid without further renewal unless notified for applications meeting the following criteria: Any of the following: continued...

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 June 2010 (continued)

continued... 1 History of one significant osteoporotic fracture demonstrated radiologically and documented bone mineral density (BMD) ≥ 2.5 standard deviations below the mean normal value in young adults (i.e. T-Score ≤ -2.5) (see Note); or 2 History of one significant osteoporotic fracture demonstrated radiologically, and either the patient is elderly, or densitometry scanning cannot be performed because of major logistical, technical or pathophysiological reasons. It is unlikely that this provision would apply to many patients under 75 years of age; or 3 History of two significant osteoporotic fractures demonstrated radiologically; or 4 Documented T-Score ≤ -3.0 (see Note); or 5 A 10-year risk of hip fracture ≥ 3%, calculated using a published risk assessment algorithm (e.g. FRAX or Dubbo) which incorporates BMD measurements (see Note). Notes: a) BMD (including BMD used to derive T-Score) must be derived measured using dual-energy x-ray absorptiometry (DXA). Quantitative ultrasound and quantitative computed tomography (QCT) are not acceptable. b) Evidence used by National Institute for Health and Clinical Excellence (NICE) guidance indicates that patients aged 75 years and over who have a history of significant osteoporotic fracture demonstrated radiologically are very likely to have a T-Score ≤ -2.5, and therefore do not require BMD measurement for treatment with bisphosphonates. c) Osteoporotic fractures are the incident events for severe (established) osteoporosis, and can be defined using the WHO definitions of osteoporosis and fragility fracture. The WHO defines severe (established) osteoporosis as a T-score below -2.5 with one or more associated fragility fractures. Fragility fractures are fractures that occur as a result of mechanical forces that would not ordinarily cause fracture (minimal trauma). The WHO has quantified this as forces equivalent to a fall from a standing height or less. d) In line with the Australian guidelines for funding alendronate, a vertebral fracture is defined as a 20% or greater reduction in height of the anterior or mid portion of a vertebral body relative to the posterior height of that body, or a 20% or greater reduction in any of these heights compared to the vertebral body above or below the affected vertebral body. NALTREXONE HYDROCHLORIDE – Special Authority see SA0909 – Retail pharmacy Tab 50 mg ........................................................................... 180.00 30 ✔ ReVia ➽ SA0909 Special Authority for Subsidy Initial application from any medical practitioner. Approvals valid for 3 months for applications meeting the following criteria: Both: 1 Patient is currently enrolled in a recognised comprehensive treatment programme for alcohol dependence; and 2 Applicant works in or with a community Alcohol and Drug Service contracted to one of the 21 District Health Boards or accredited against the New Zealand Alcohol and Other Drug Sector Standard or the National Mental Health Sector Standard. Renewal from any medical practitioner. Approvals valid for 3 months for applications meeting the following criteria: Both: 1 Compliance with the medication (prescriber determined); and 2 Any of the following: 2.1 Patient is still unstable and requires further treatment; or 2.2 Patient achieved significant improvement but requires further treatment; or 2.3 Patient is well controlled but requires maintenance therapy. The patient may not have had more than 1 prior approval in the last 12 months.

135

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 June 2010 (continued)

138 CYTARABINE Inj 500 mg 100 mg per ml, 5 ml – PCT – Retail pharmacy-Specialist ................................................... 18.15 95.36 Inj 1 g 100 mg per ml, 10 ml – PCT – Retail pharmacy-Specialist .................................................. 37.00 42.65 Inj 2 g 100 mg per ml, 20 ml – PCT only – Specialist ............... 31.00 34.47 CYTARABINE Inj 1 mg for ECP – PCT only – Specialist ................................... 0.30

1 5 1 1 1 1 10 1 mg

✔ Pfizer ✔ Mayne ✔ Pfizer ✔ Mayne ✔ Pfizer ✔ Mayne ✔ Baxter

138

Effective 1 May 2010

34 DOCUSATE SODIUM – Only on a prescription ❋ Tab Cap 50 mg ......................................................................... 3.95 ❋ Tab Cap 120 mg ....................................................................... 5.49 CALCIUM CARBONATE ❋ Tab eff 1.75 g (1 g elemental) .................................................. 6.54 CALCIUM CARBONATE ❋ Tab 1.25 g (500 mg elemental) ................................................ 9.18 ❋ Tab 1.5 g (600 mg elemental) ................................................ 10.33 SODIUM FLUORIDE Tab 1.1 mg (0.5 mg elemental) ................................................ 4.00 FERROUS FUMARATE Tab 200 mg (65 mg elemental) ................................................ 4.35 FERROUS FUMARATE WITH FOLIC ACID Tab 310 mg (100 mg elemental) with folic acid 350 µg ............ 4.75 FERROUS GLUCONATE WITH ASCORBIC ACID ❋ Tab 170 mg (20 mg elemental) with ascorbic acid 40 mg ....... 12.04 FERROUS SULPHATE ❋ Tab long-acting 325 mg (105 mg elemental) ............................ 5.06 (15.58) ❋‡ Oral liq 150 mg per 5 ml (30 mg elemental per 1 ml) ........... 10.30 FERROUS SULPHATE WITH FOLIC ACID ❋ Tab long-acting 325 mg (105 mg elemental) with folic acid 350 µg .................................................................. 1.80 (3.73) MAGNESIUM SULPHATE Inj 49.3%, 5 ml ....................................................................... 26.60 Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber. 100 100 30 250 250 100 100 60 500 ✔ Laxofast 50 ✔ Laxofast 120 ✔ Calsource ✔ Calci-Tab 500 ✔ Calci-Tab 600 ✔ PSM ✔ Ferro-tab ✔ Ferro-F-Tabs ✔ Healtheries Iron with Vitamin C

38 38

38 38 38 38

150 500 ml Ferro-Gradumet ✔ Ferodan

30 Ferrograd-Folic 10 ✔ Mayne

▲

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 May 2010 (continued)

39 138 ZINC SULPHATE ❋ Cap 220 137.4 mg (50 mg elemental) ................................... 10.00 100 ✔ Zincaps

GEMCITABINE HYDROCHLORIDE – PCT only – Specialist – Special Authority see SA1012 0877 Inj 1 g ................................................................................... 245.00 1 ✔ Gemcitabine Ebewe 349.20 ✔ Gemzar Inj 200 mg .............................................................................. 49.00 1 ✔ Gemcitabine Ebewe 78.00 ✔ Gemzar Inj 1 mg for ECP ....................................................................... 0.26 1 mg ✔ Baxter ➽ SA1012 0877 Special Authority for Subsidy Initial application - (Hodgkin’s disease) only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 12 months for applications meeting the following criteria: All of the following 1 The patient has Hodgkin’s disease*; and 2 Either 2.1 Disease has failed to respond to second-line salvage chemotherapy treatment; or 2.2 Disease has relapsed following transplant; or 2.3 The patient is unsuitable for, or intolerant to, second-line salvage chemotherapy or high dose chemotherapy and transplant. 3 Gemcitabine to be given for a maximum of 6 treatment cycles. Initial application - (T-cell Lymphoma) only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 12 months for applications meeting the following criteria: All of the following 1 The patient has T-cell lymphoma*; and 2 Gemcitabine to be given for a maximum of 6 treatment cycles. Initial application - (Other indications) only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 12 months for applications meeting the following criteria: Any of the following: 1 The patient has non small cell lung carcinoma (stage IIIa, or above); or 2 The patient has advanced malignant mesothelioma*; or 3 The patient has advanced pancreatic carcinoma; or 4 The patient has ovarian, fallopian tube* or primary peritoneal carcinoma*; or 5 The patient has advanced transitional cell carcinoma of the urothelial tract (locally advanced or metastatic). Renewal - (Other Indications) only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 12 months for applications meeting the following criteria: Either: 1 The patient requires continued therapy; or 2 The tumour has relapsed and requires re-treatment. Note: Indications marked with a * are Unapproved Indications.

143

VINORELBINE – PCT only – Specialist – Special Authority see SA1013 0901 Inj 10 mg per ml, 1 ml ............................................................ 24.00 1 42.00 Inj 10 mg per ml, 5 ml ........................................................... 120.00 1 210.00 Inj 1 mg for ECP ........................................................................ 2.71 1 mg

✔ Navelbine ✔ Vinorelbine Ebewe ✔ Navelbine ✔ Vinorelbine Ebewe ✔ Baxter continued...

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

S29

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 May 2010 (continued)

continued... ➽ SA1013 0901 Special Authority for Subsidy Initial application - (Hodgkin’s disease) only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 12 months for applications meeting the following criteria: All of the following 1 The patient has Hodgkin’s disease*; and 2 Either 2.1 Disease has failed to respond to second-line salvage chemotherapy treatment; or 2.2 Disease has relapsed following transplant; or 2.3 The patient is unsuitable for, or intolerant to, second-line salvage chemotherapy or high dose chemotherapy and transplant. 3 Vinorelbine to be given for a maximum of 6 treatment cycles. Initial application - (T-cell Lymphoma) only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 12 months for applications meeting the following criteria: All of the following 1 The patient has T-cell lymphoma*; and 2 Vinorelbine to be given for a maximum of 6 treatment cycles. Initial application – (Other indications) only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 12 months for applications meeting the following criteria: Any of the following: 1 The patient has metastatic breast cancer; or 2 The patient has non-small cell lung cancer (stage IIIa, or above); or 3 All of the following: 3.1 The patient has stage IB-IIIA non-small cell lung cancer; and 3.2 Vinorelbine is to be given as adjuvant treatment in combination with cisplatin; and 3.3 The patient has good performance status (WHO/ECOG grade 0-1). Renewal – (Other Indications) only from a relevant specialist or medical practitioner on the recommendation of a relevant specialist. Approvals valid for 12 months for applications meeting the following criteria: Either: 1 The patient requires continued therapy; or 2 The tumour has relapsed and requires re-treatment. Note: Indications marked with a * are Unapproved Indications.

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price

Effective 1 June 2010

34 DOCUSATE SODIUM – Only on a prescription ( subsidy) ❋ Tab 50 mg ............................................................................... 3.95 (4.89) ❋ Tab 120 mg .............................................................................. 5.49 (6.73) RISPERIDONE ( subsidy) Tab 0.5 mg ............................................................................... 1.17 3.51 Tab 1 mg .................................................................................. 6.00 Tab 2 mg ................................................................................ 11.00 Tab 3 mg ................................................................................ 15.00 Tab 4 mg ................................................................................ 20.00 100 Coloxyl 100 Coloxyl 20 60 60 60 60 60 ✔ Ridal ✔ Ridal ✔ Ridal ✔ Ridal ✔ Ridal ✔ Ridal

125

138

CYTARABINE Inj 100 mg – PCT – Retail pharmacy-Specialist ( subsidy) ..... 76.00 5 ✔ Pfizer Inj 1 mg for ECP – PCT only – Specialist ( subsidy) ................. 0.30 10 mg ✔ Baxter Note - Baxter inj 1 mg for ECP subsidy and price increase is pro rated to the new 10 mg pack size. VINCRISTINE SULPHATE Inj 1 mg per ml, 1 ml – PCT – Retail pharmacy-Specialist ( subsidy) .............................. 108.00 Inj 1 mg per ml, 2 ml – PCT – Retail pharmacy-Specialist ( subsidy) .............................. 116.00 Inj 1 mg for ECP – PCT only – Specialist ( subsidy) ............... 15.77

143

5 5 1 mg

✔ Hospira ✔ Hospira ✔ Baxter

156

BECLOMETHASONE DIPROPIONATE ( price) Metered aqueous nasal spray, 50 µg per dose ........................... 2.35 200 dose OP (4.00) Metered aqueous nasal spray, 100 µg per dose ......................... 2.46 200 dose OP (4.81)

Alanase Alanase

Effective 1 May 2010

61 CROTAMITON ( subsidy) a) Only on a prescription b) Not in combination Crm 10% .................................................................................. 3.79 (4.45)

20 g OP Eurax

CHLORHEXIDINE GLUCONATE – Subsidy by endorsement ( subsidy) a) No more than 500 ml per month b) Only if prescribed for a dialysis patient and the prescription is endorsed accordingly. ❋ Handrub 1% with ethanol 70% .................................................. 4.60 500 ml (5.40) PREGNANCY TESTS - HCG URINE ( subsidy) a) Up to 200 test available on a PSO b) Only on a PSO Cassette ................................................................................. 14.25

Orion

25 test OP ✔ MDS Quick Card

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturers Price - effective 1 May 2010 (continued)

95 LAMIVUDINE – Special Authority see SA0779 – Hospital pharmacy [HP1] ( subsidy) Tab 150 mg ......................................................................... 153.60 60 ✔ 3TC Oral liq 10 mg per ml .............................................................. 50.00 240 ml OP ✔ 3TC CISPLATIN – PCT only – Specialist ( subsidy) Inj 1 mg per ml, 50 ml ............................................................ 15.00 Inj 1 mg per ml, 100 ml .......................................................... 21.00 MEGESTROL ACETATE – Retail pharmacy-Specialist ( subsidy) Tab 160 mg ........................................................................... 57.92 (74.25) 1 1 30 Megace ✔ Cisplatin Ebewe ✔ Cisplatin Ebewe

136

146

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Brand Name

Effective 1 June 2010

76 DEXAMETHASONE SODIUM PHOSPHATE ❋ Inj 4 mg per ml, 1 ml – Up to 5 inj available on a PSO .............. 21.50 ❋ Inj 4 mg per ml, 2 ml – Up to 5 inj available on a PSO .............. 31.00 CYTARABINE Inj 100 mg – PCT – Retail pharmacy-Specialist. ...................... 76.00 VINCRISTINE SULPHATE Inj 1 mg per ml, 1 ml – PCT – Retail pharmacy-Specialist ..... 108.00 Inj 1 mg per ml, 2 ml – PCT – Retail pharmacy-Specialist ..... 116.00 5 5 5 5 5 ✔ Hospira Mayne ✔ Hospira Mayne ✔ Pfizer Pharmacia ✔ Hospira Mayne ✔ Hospira Mayne

138 143

Changes to Sole Subsidised Supply

Effective 1 June 2010

For the list of new Sole Subsidised Supply products effective 1 June 2010 refer to the bold entries in the cumulative Sole Subsidised Supply table pages 10-18.

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items

Effective 1 June 2010

27 28 ATROPINE SULPHATE ❋ Inj 1200 µg, 1 ml – Up to 5 inj available on a PSO.................... 32.00 OMEPRAZOLE ❋ Cap 10 mg ............................................................................... 2.00 ❋ Cap 40 mg .............................................................................. 3.35 50 28 28 ✔ AstraZeneca ✔ Dr Reddy’s Omeprazole ✔ Dr Reddy’s Omeprazole

Note – Dr Reddy’s Omeprazole cap 10 mg and 40 mg, 30 cap pack, remain listed. 44 52 POTASSIUM CHLORIDE ❋ Inj 150 mg per ml, 10 ml ......................................................... 26.00 ATENOLOL ❋ Tab 50 mg ................................................................................ 0.39 PINDOLOL ❋ Tab 5 mg .................................................................................. 4.50 ❋ Tab 10 mg ................................................................................ 8.35 ❋ Tab 15 mg .............................................................................. 12.00 50 ✔ AstraZeneca

30 100 100 100

✔ Noten S29 ✔ Pindol ✔ Pindol ✔ Pindol

ETHINYLOESTRADIOL WITH GESTODENE ❋ Tab 30 µg with gestodene 75 µg and 7 inert tab ........................ 6.62 84 (16.50) a) Higher subsidy of $14.49 per 84 tab with Special Authority see SA0500 above b) Up to 84 tab available on a PSO FLUCLOXACILLIN SODIUM Cap 250 mg – Up to 30 cap available on a PSO ....................... 18.50 Cap 500 mg ............................................................................ 57.90 DICLOFENAC SODIUM ❋ Tab long-acting 75 mg ............................................................ 19.60 CLOMIPRAMINE HYDROCHLORIDE Tab 10 mg .............................................................................. 10.00 PARACETAMOL WITH CODEINE ❋ Tab paracetamol 500 mg with codeine phosphate 8 mg ............ 2.45 (3.24) BROMOCRIPTINE MESYLATE ❋ Tab 2.5 mg ............................................................................ 32.08 BLEOMYCIN SULPHATE – PCT only – Specialist Inj 15,000 iu .......................................................................... 680.00 250 500 100 100 100

Femodene 28

✔ Staphlex ✔ Staphlex ✔ Voltaren SR ✔ Clopress

100 112 112

Codalgin 100 ✔ AlphaBromocriptine ✔ Blenoxane

121

140

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items - effective 1 May 2010

30 METFORMIN HYDROCHLORIDE ❋ Tab immediate-release 500 mg ................................................. 8.09 ❋ Tab immediate-release 850 mg ................................................. 6.67 CALCITRIOL ❋ Cap 0.25 µg ........................................................................... 10.10 ❋ Cap 0.5 µg ............................................................................. 18.73 PERMETHRIN Crm 5% .................................................................................... 3.65 (4.20) WOOL FAT WITH MINERAL OIL – Only on a prescription ❋ Lotn hydrous 3% with mineral oil .............................................. 1.12 (5.00) 2.10 (9.38) 500 250 100 100 30 g OP Lyderm 200 ml OP Alpha-Keri Lotion 375 ml OP Alpha-Keri Lotion ✔ Arrow-Metformin ✔ Arrow-Metformin ✔ Calcitriol-AFT ✔ Calcitriol-AFT

SUNSCREENS, PROPRIETARY – Subsidy by endorsement Only if prescribed for a patient with severe photosensitivity secondary to a defined clinical condition and the prescription is endorsed accordingly. Lotn ......................................................................................... 3.19 125 ml OP (8.82) Aquasun Sensitive SPF 30+ AMOXYCILLIN Grans for oral liq 250 mg per 5 ml – Up to 200 ml available on a PSO ............................................................................... 1.27 LAMOTRIGINE ▲ Tab dispersible 200 mg ........................................................ 101.80 SUMATRIPTAN Tab 50 mg ............................................................................... 1.55 (12.00) (22.00) Tab 100 mg ............................................................................. 1.55 (12.00) (22.00) TENIPOSIDE – PCT only – Specialist Inj 10 mg per ml, 5 ml .......................................................... 845.11 Inj 50 mg for ECP ................................................................... 84.51 DEXTROCHLORPHENIRAMINE MALEATE ❋ Tab 2 mg ................................................................................. 1.26 (5.60) 2.52 (9.99)

100 ml 56 4

✔ Ranbaxy Amoxicillin ✔ Arrow-Lamotrigine

117 119

Sumagran Imigran 2 Sumagran Imigran 10 ✔ Vumon 50 mg OP ✔ Baxter 25 Polaramine 50 Polaramine

143

151

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted

Effective 1 August 2010

61 CROTAMITON a) Only on a prescription b) Not in combination Crm 10% .................................................................................. 3.79 (4.45)

20 g OP Eurax

CHLORHEXIDINE GLUCONATE – Subsidy by endorsement a) No more than 500 ml per month b) Only if prescribed for a dialysis patient and the prescription is endorsed accordingly. ❋ Handrub 1% with ethanol 70% .................................................. 4.60 500 ml (5.40) PREGNANCY TESTS - HCG URINE a) Up to 200 test available on a PSO b) Only on a PSO Cassette ................................................................................. 14.25 DICLOFENAC SODIUM ❋ Tab long-acting 75 mg ............................................................. 3.10 Note – Diclax SR tab long-acting 75 mg, 500 tab pack, remains listed. DEXTROPROPOXYPHENE WITH PARACETAMOL Tab napsylate 50 mg with paracetamol 325 mg ...................... 14.50 (22.50) Cap hydrochloride 32.5 mg with paracetamol 325 mg ............... 3.98 (4.90) 19.91 (33.14) MEGESTROL ACETATE – Retail pharmacy-Specialist Tab 160 mg ........................................................................... 57.92 (74.25)

Orion

25 test OP ✔ MDS Quick Card 30 ✔ Diclax SR

100

110

500 Paradex 100 Capadex 500 Capadex

146

30 Megace

Effective 1 September 2010

34 DOCUSATE SODIUM – Only on a prescription ❋ Tab 50 mg ................................................................................ 3.95 (4.89) ❋ Tab 120 mg .............................................................................. 5.49 (6.73) 100 Coloxyl 100 Coloxyl

Effective 1 November 2010

55 62 FUROSEMIDE ❋ Tab 500 mg ........................................................................... 12.00 HYDROCORTISONE ❋ Crm 1% – Only on a prescription .............................................. 2.44 Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber. 100 100 g ✔ Diurin 500 ✔ Lemnis Fatty Cream HC

▲

❋ Three months or six months, as applicable, dispensed all-at-once

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted - effective 1 November 2010 (continued)

72 ETHINYLOESTRADIOL WITH LEVONORGESTREL ❋ Tab ethinyloestradiol 30 µg with levonorgestrel 50 µg (6) and tab ethinyloestradiol 40 µg with levonorgestrel 75 µg (5), and tab ethinyloestradiol 30 µg with levonorgestrel 125 µg (10) and 7 inert tab – Up to 84 tab available on a PSO................ 6.62 DYDROGESTERONE Tab 10 mg ............................................................................. 27.50 (29.90) Note – Duphaston tab 10 mg, 28 tab pack remains listed. DANAZOL – Retail pharmacy-Specialist Cap 200 mg ........................................................................... 29.35 DICLOFENAC SODIUM ❋ Tab EC 25 mg ........................................................................... 1.63 ❋ Tab EC 50 mg ........................................................................... 2.13 ❋ Tab long-acting 75 mg ........................................................... 22.78 ❋ Tab long-acting 100 mg ......................................................... 34.32 Note – Diclax SR tab long-acting 75 mg, 500 tab pack, remains listed. CLOMIPRAMINE HYDROCHLORIDE Tab 25 mg ............................................................................. 26.00

84 50

✔ Trifeme

Duphaston

83 100

30 50 50 500 500

✔ D-Zol ✔ Diclohexal ✔ Diclohexal ✔ Apo-Diclo SR ✔ Apo-Diclo SR

112 113

500

✔ Clopress

MOCLOBEMIDE Note: There is a significant cost differential between moclobemide and fluoxetine (moclobemide being about three times more expensive). For depressive syndromes it is therefore more cost-effective to start treatment with fluoxetine first before considering prescribing moclobemide. Tab 150 mg ............................................................................. 8.31 60 ✔ GenRx Moclobemide Tab 300 mg ........................................................................... 18.80 60 ✔ GenRx Moclobemide FLUOROURACIL SODIUM Inj 50 mg per ml, 10 ml – PCT only – Specialist ......................... 4.95 1 ✔ Fluorouracil Ebewe Note – Fluorouracil Ebewe inj 50 mg per ml, 10 ml, 5 injection pack listed 1 May 2010.

138

Effective 1 December 2010

27 OMEPRAZOLE, AMOXYCILLIN AND CLARITHROMYCIN Omeprazole cap 20 mg × 14, amoxycillin cap 500 mg × 28 and clarithromycin tab 500 mg × 14 .................................. 55.00 HEPARIN SODIUM Inj 5,000 iu per ml, 5 ml .......................................................... 43.67 KETOCONAZOLE Crm 2% ..................................................................................... 1.00 (9.50) a) Only on a prescription b) Not in combination

1 OP 10 15 g OP

✔ Losec Hp7 OAC ✔ Multiparin

43 60

Nizoral

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted - effective 1 December 2010 (continued)

179 ENTERAL FEED 1KCAL/ML – Special Authority see SA0702 – Hospital pharmacy [HP3] Liquid ........................................................................................ 1.24 250 ml OP ✔ Isosource HN 5.29 1,000 ml OP ✔ Isosource HN RTH ENTERAL FEED WITH FIBRE 1 KCAL/ML – Special Authority see SA0702 – Hospital pharmacy [HP3] Liquid .................................................................................... 1.24 250 ml OP ✔ Fibersource HN 5.29 1,000 ml OP ✔ Fibersource HN RTH ENTERAL FEED WITH FIBRE 1.5KCAL/ML – Special Authority see SA0702 – Hospital pharmacy [HP3] Liquid ........................................................................................ 7.00 1,000 ml OP ✔ Isosource 1.5 ORAL FEED 1.5KCAL/ML – Special Authority see SA0702 – Hospital pharmacy [HP3] Liquid (vanilla) .......................................................................... 1.33 237 ml OP ✔ Resource Plus FOOD THICKENER – Special Authority see SA0595 – Hospital pharmacy [HP3] Powder ..................................................................................... 3.80 250 g OP ✔ Resource Thicken Up

179

179 180 181

▲

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes to Part II

Effective 1 June 2010

BECLOMETHASONE DIPROPIONATE ( price) Metered aqueous nasal spray, 50 µg per dose ..........................Alanase Metered aqueous nasal spray, 100 µg per dose ........................Alanase CYTARABINE Inj 100 mg......................................Pfizer

4.00 4.81 76.00

200 dose 200 dose 5 1% Aug-10 Mayne Mayne Mayne Mayne

CYTARABINE (new listing and amended description) Inj 500 mg 100 mg per ml, 5 ml .....Pfizer 18.15 1 1% Aug-10 Inj 1 g 100 mg per ml, 10 ml ..........Pfizer 37.00 1 1% Aug-10 Inj 2 g 100 mg per ml, 20 ml ..........Pfizer 31.00 1 1% Aug-10 Note – Mayne’s brand of cytarabine inj 500 mg, 1 g and 2 g to be delisted 1 August 2010. DEXAMETHASONE SODIUM PHOSPHATE (amended brand name and addition of HSS) Inj 4 mg per ml, 1 ml ......................Hospira Mayne 21.50 5 1% Inj 4 mg per ml, 2 ml ......................Hospira Mayne 31.00 5 1% ENALAPRIL Tab 5 mg........................................Arrow-Enalapril Tab 10 mg......................................Arrow-Enalapril Tab 20 mg......................................Arrow-Enalapril 1.98 2.44 3.24 90 90 90 1% 1% 1% Aug-10 Aug-10 Aug-10 Aug-10 Aug-10

(B) (B) m-Enalapril Redopril Renitec m-Enalapril Redopril Renitec m-Enalapril Redopril Renitec Camptosar DBL Irinotecan Irinotecan Actavis 40 Mylan Camptosar DBL Irinotecan Irinotecan Actavis 100 Mylan

IRINOTECAN Inj 20 mg per ml, 2 ml ....................Irinotecan-Rex

41.00

Aug-10

Inj 20 mg per ml, 5 ml ....................Irinotecan-Rex 100.00

Aug-10

Note – Camptosar inj 20 mg per ml, 2 ml and 5 ml to be delisted 1 August 2010.

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes Part II - effective 1 June 2010 (continued)

PROPOFOL ( price) Inj 1%, 20 ml .................................Diprivan Provive 1% Inj 1%, 50 ml .................................Diprivan Provive 1% Inj 1%, 100 ml ................................Diprivan Provive 1% RISPERIDONE ( price) Tab 0.5 mg.....................................Ridal Ridal Tab 1 mg........................................Ridal Tab 2 mg........................................Ridal Tab 3 mg........................................Ridal Tab 4 mg........................................Ridal TRAMADOL HYDROCHLORIDE Cap 50 mg .....................................Arrow-Tramadol Note – Tramal cap 50 mg to be delisted 1 August 2010. VINCRISTINE SULPHATE ( price, amended brand name and addition of HSS) Inj 1 mg per ml, 1 ml ......................Hospira Mayne 108.00 5 Inj 1 mg per ml, 2 ml ......................Hospira Mayne 116.00 5 1% 1% Aug-10 Aug-10 (B) (B) 10.21 10.21 5.56 5.56 9.28 9.28 1.17 3.51 6.00 11.00 15.00 20.00 6.95 5 5 1 1 1 1 20 60 60 60 60 60 100 1% Aug-10 AFT Tramal Tramedo

Effective 1 May 2010

BENDROFLUAZIDE Tab 2.5 mg.....................................Arrow7.58 Bendrofluazide Tab 5 mg........................................Arrow11.75 Bendrofluazide 500 500 1% 1% Jul-10 Jul-10 Neo-Naclex Neo-Naclex

CISPLATIN ( price and addition of HSS) Inj 1 mg per ml, 50 ml ....................Cisplatin Ebewe 15.00 1 1% Jul-10 Inj 1 mg per ml, 100 ml ..................Cisplatin Ebewe 21.00 1 1% Jul-10 Note – Mayne cisplatin inj 1 mg per ml, 50 ml and 100 mg, to be delisted 1 July 2010. CLINDAMYCIN (addition of HSS) Inj phosphate 150 mg per ml, 4 ml ..................Dalacin C

DBL Cisplatin DBL Cisplatin

16.00

1 500

Jul-10

(B)

CLOMIPRAMINE HYDROCHLORIDE Tab 25 mg......................................Clopress 26.00 Note – Clopress tab 25 mg to be delisted 1 July 2010. DANAZOL Cap 200 mg ...................................D-Zol 29.35 Note– D-Zol cap 200 mg to be delisted 1 November 2010.

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes Part II - effective 1 May 2010 (continued)

DOCUSATE SODIUM (correction of presentation) Cap tab 50 mg ...............................Laxofast 50 Cap tab 120 mg .............................Laxofast 120 3.95 5.49 100 100 1% 1% Jun-10 Jun-10 Coloxyl Coloxyl Mayne

FLUOROURACIL SODIUM (addition of new pack size) Inj 50 mg per ml, 10 ml ..................Fluorouracil 24.75 5 1% Oct-07 Ebewe Note – Fluorouracil Ebewe inj 50 mg per ml, 10 ml, 1 injection pack, to be delisted 1 July 2010. FUROSEMIDE Tab 500 mg....................................Diurin 500 12.00 Note – Diurin 500 tab 500 mg to be delisted 1 July 2010. LIGNOCAINE Gel 2%, 10 ml urethral syringe .......Pfizer MEDROXYPROGESTERONE ACETATE (addition of HSS) Inj 150 mg per ml, 1 ml, syringe .....Depo-Provera 43.26 7.15 100

10 1 30 100 30 100 30 1% 1% 1% 1% 1% 1% Jul-10 Jul-10 Jul-10 Jul-10 Jul-10 Jul-10 May-10 May-10 (B) Cycrin Cycrin Cycrin (B) (B) GenRx Moclobemide GenRx Moclobemide

MEDROXYPROGESTERONE ACETATE (continuation of HSS) Tab 2.5 mg.....................................Provera 3.09 Tab 5 mg........................................Provera 13.06 Tab 10 mg......................................Provera 6.85 Tab 100 mg....................................Provera 96.50 Tab 200 mg....................................Provera 70.50

MOCLOBEMIDE (reinstatement of HSS) Tab 150 mg....................................Apo69.23 500 1% Moclobemide Tab 300 mg....................................Apo31.33 100 1% Moclobemide Note – GenRx Moclobemide tab 150 mg and 300 mg to be delisted 1 May 2010. TENOXICAM Inj 20 mg........................................AFT TESTOSTERONE UNDECANOATE Cap 40 mg ....................................ArrowTestosterone 9.95 79.92 1 100 1% 1%

Jul-10 Jul-10

(B) Andriol Testocaps Panteston

Effective 1 April 2010

AMBRISENTAN Tab 5 mg........................................Volibris Tab 10 mg......................................Volibris BISACODYL Suppos 5 mg..................................Dulcolax Suppos 10 mg................................Dulcolax CHLORAMPHENICOL ( price) Eye drops 0.5% .............................Chlorsig Products with Hospital Supply Status (HSS) are in bold. 4,585.00 4,585.00 3.00 3.00 2.40 30 30 6 6 10 ml (B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes Part II - effective 1 April 2010 (continued)

CIPROFLOXACIN ( price and addition of HSS) Inj 2 mg per ml, 100 ml ..................Aspen Ciprofloxacin 41.00 10 1% Jun-10 Ciproxin DBL DP-Cipro Topistin Ufexil

DANAZOL Cap 200 mg ...................................Azol DIHYDROCODEINE TARTRATE Tab long-acting 60 mg....................DHC Continus DOCUSATE SODIUM Tab 50 mg......................................Laxofast 50 Tab 120 mg....................................Laxofast 120

97.83 27.27 3.95 5.49

100 60 100 100 1% 1% 1% Jun-10 Jun-10 Jun-10 (B) Coloxyl Coloxyl

DOCUSATE SODIUM WITH SENNOSIDES ( price and addition of HSS) Tab 50 mg with total sennosides 8 mg .......................Laxsol 6.38 200 HYDROCORTISONE Crm 1% ..........................................Pharmacy Health 3.75 100 g

Jun-10

Coloxyl with Senna

HYDROCORTISONE WITH NATAMYCIN AND NEOMYCIN (Amended chemical name) Crm 1% with natamycin 1% and neomycin sulphate 0.5% ............Pimafucort 2.79 15 g Oint 1% with natamycin 1% and neomycin sulphate 0.5% ............Pimafucort 2.79 15 g OMEPRAZOLE Cap 10 mg .....................................Dr Reddy’s 2.00 28 1% May-09 Losec Omeprazole Omezol Cap 20 mg .....................................Dr Reddy’s 2.85 28 1% May-09 Losec Omeprazole Omezol Cap 40 mg .....................................Dr Reddy’s 3.35 28 1% May-09 Losec Omeprazole Omezol Note – Dr Reddy’s Omeprazole cap 10 mg, 20 mg and 40 mg, 28 cap packs, to be delisted 1 June 2010. Please note that the 30 capsule packs remain listed. PIPERACILLIN SODIUM WITH TAZOBACTAM SODIUM Inj 4 g with tazobactam sodium 500 mg .........................Tazocin EF

12.00

Jun-10

DBL Zobacin

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Contracted Pharmaceutical Description

Brand

Price ($) (ex man. excl. GST)

Per

DV Limit

DV Limit DV applies Pharmaceutical from

Section H changes Part II - effective 1 April 2010 (continued)

TOPIRAMATE Tab 25 mg......................................Arrow -Topiramate Tab 50 mg......................................Arrow -Topiramate Tab 100 mg....................................Arrow -Topiramate Tab 200 mg....................................Arrow -Topiramate TRANEXAMIC ACID ( price and addition of HSS) Tab 500 mg....................................Cyclokapron ZIDOVUDINE (AZT) Cap 100 mg ...................................Retrovir Oral liq 10 mg per ml ......................Retrovir 11.07 18.81 31.99 55.19 60 60 60 60

32.92 145.00 29.00

100 100 200 ml

1% 1% 1%

Jun-10 Jun-10 Jun-10

(B) (B) (B)

Section H changes to Part IV

Effective 1 April 2010

CLOPIDOGREL Tab 75 mg Plavix Up to 4 weeks supply post stenting. Not to be funded for acute coronary syndrome or transient ischaemic attacks.

Products with Hospital Supply Status (HSS) are in bold.

(B) – Subject only to part (b) of the definition of “DV Pharmaceutical”

Index

Pharmaceuticals and brands Symbols 3TC ................................................................... 27 A Alanase........................................................ 26, 34 Alendronate sodium ........................................... 21 Alendronate sodium with cholecalciferol ............. 21 Alpha-Bromocriptine .......................................... 29 Alpha-Keri Lotion ............................................... 30 Ambrisentan ...................................................... 36 Amoxycillin ........................................................ 30 Apo-Diclo SR ..................................................... 32 Apo-Moclobemide.............................................. 36 Aquasun Sensitive SPF 30+ .............................. 30 Arrow ................................................................ 19 Arrow-Bendrofluazide ................................... 19, 35 Arrow-Enalapril ............................................ 19, 34 Arrow-Lamotrigine ............................................. 30 Arrow-Metformin................................................ 30 Arrow-Testosterone ..................................... 19, 36 Arrow-Topiramate .............................................. 38 Arrow-Tramadol ........................................... 19, 35 Aspen Ciprofloxacin ........................................... 37 Atenolol ............................................................. 29 Atropine sulphate ............................................... 29 Azol ................................................................... 37 B Beclomethasone dipropionate....................... 26, 34 Bendrofluazide ............................................. 19, 35 Bisacodyl ........................................................... 36 Blenoxane .......................................................... 29 Bleomycin sulphate ............................................ 29 Bromocriptine mesylate...................................... 29 C Calcitriol ............................................................ 30 Calcitriol-AFT ..................................................... 30 Calci-Tab 500 .................................................... 23 Calci-Tab 600 .................................................... 23 Calcium carbonate ............................................. 23 Calsource .......................................................... 23 Capadex............................................................. 31 Chloramphenicol ................................................ 36 Chlorhexidine gluconate ............................... 26, 31 Chlorsig ............................................................. 36 Ciprofloxacin ...................................................... 37 Cisplatin....................................................... 27, 35 Cisplatin Ebewe............................................ 27, 35 Clindamycin ....................................................... 35 Clomipramine hydrochloride ................... 29, 32, 35 Clopidogrel ........................................................ 38 Clopress ................................................ 29, 32, 35 Combined oral contraceptives ............................ 20 Cotazym ECS ..................................................... 20 Codalgin ............................................................ 29 Coloxyl ........................................................ 26, 31 Creon 10000...................................................... 20 Creon Forte ........................................................ 20 Crotamiton ................................................... 26, 31 Cyclokapron....................................................... 38 Cytarabine ................................. 19, 23, 26, 28, 34 D D-Zol ........................................................... 32, 35 Dalacin C ........................................................... 35 Danazol.................................................. 32, 35, 37 Deca-Durabolin Orgaject .................................... 19 Depo-Provera ..................................................... 36 Derbac-M .......................................................... 20 Dexamethasone sodium phosphate .............. 28, 34 Dextrochlorpheniramine maleate ......................... 30 Dextropropoxyphene with paracetamol ............... 31 DHC Continus .................................................... 37 Diclax SR ........................................................... 31 Diclofenac Sandoz ............................................... 19 Diclofenac sodium ........................... 19, 29, 31, 32 Diclohexal .......................................................... 32 Dihydrocodeine tartrate ...................................... 37 Diprivan ............................................................. 35 Diurin 500 .................................................... 31, 36 Docusate sodium ....................... 23, 26, 31, 36, 37 Docusate sodium with sennosides ..................... 37 Dr Reddy’s Omeprazole................................ 29, 37 Dulcolax............................................................. 36 Duphaston ......................................................... 32 Dydrogesterone.................................................. 32 E Enalapril ....................................................... 19, 34 Enteral feed 1kcal/ml .......................................... 33 Enteral feed with fibre 1.5kcal/ml ........................ 33 Enteral feed with fibre 1 kcal/ml .......................... 33 Ethinyloestradiol with gestodene ......................... 29 Ethinyloestradiol with levonorgestrel ................... 32 Eurax ........................................................... 26, 31 F Femodene 28 ..................................................... 29 Ferodan ....................................................... 20, 23 Ferro-F-Tabs ...................................................... 23 Ferro-Gradumet.................................................. 23 Ferro-tab ............................................................ 23 Ferrograd-Folic................................................... 23 Ferrous fumarate ................................................ 23 Ferrous fumarate with folic acid .......................... 23 Ferrous gluconate with ascorbic acid .................. 23 Ferrous sulphate .......................................... 20, 23 Ferrous sulphate with folic acid .......................... 23 Fibersource HN .................................................. 33

Index

Pharmaceuticals and brands Fibersource HN RTH........................................... 33 Flucloxacillin sodium .......................................... 29 Fluorouracil Ebewe ................................. 19, 32, 36 Fluorouracil sodium................................ 19, 32, 36 Food thickener ................................................... 33 Fosamax ............................................................ 21 Fosamax Plus .................................................... 21 Furosemide .................................................. 31, 36 G Gemcitabine Ebewe............................................ 24 Gemcitabine hydrochloride ................................. 24 Gemzar .............................................................. 24 GenRx Moclobemide .......................................... 32 H Healtheries Iron with Vitamin C ........................... 23 Heparin sodium.................................................. 32 Hydrocortisone ............................................ 31, 37 Hydrocortisone with natamycin and neomycin .... 37 I Imigran .............................................................. 30 Irinotecan..................................................... 19, 34 Irinotecan-Rex.............................................. 19, 34 Isosource 1.5..................................................... 33 Isosource HN ..................................................... 33 Isosource HN RTH ............................................. 33 K Ketoconazole ..................................................... 32 L Lamivudine ........................................................ 27 Lamotrigine........................................................ 30 Laxofast 50 ............................................ 23, 36, 37 Laxofast 120 .......................................... 23, 36, 37 Laxsol ................................................................ 37 Lemnis Fatty Cream HC...................................... 31 Lignocaine ................................................... 19, 36 Losec Hp7 OAC ................................................. 32 Lyderm .............................................................. 30 M Magnesium sulphate .......................................... 23 Malathion ........................................................... 20 MDS Quick Card .......................................... 26, 31 Medroxyprogesterone acetate............................. 36 Megace........................................................ 27, 31 Megestrol acetate......................................... 27, 31 Metformin hydrochloride .................................... 30 Mitomycin C ...................................................... 19 Moclobemide ............................................... 32, 36 Multiparin........................................................... 32 N Naltrexone hydrochloride .................................... 22 Nandrolone decanoate........................................ 19 Navelbine ........................................................... 24 Nizoral ............................................................... 32 Noten ................................................................. 29 O Omeprazole.................................................. 29, 37 Omeprazole, amoxycillin and clarithromycin ....... 32 Oral feed 1.5kcal/ml ........................................... 33 P Pancreatic enzyme ............................................. 20 Panzytrat............................................................ 20 Paracetamol with codeine .................................. 29 Paradex ............................................................. 31 Permethrin ......................................................... 30 Pharmacy Health ................................................ 37 Pimafucort ......................................................... 37 Pindol ................................................................ 29 Pindolol ............................................................. 29 Piperacillin sodium with tazobactam sodium ....... 37 Plavix ................................................................. 38 Polaramine......................................................... 30 Potassium chloride ............................................ 29 Pregnancy tests - hcg urine .......................... 26, 31 Progestogen-only contraceptives........................ 20 Propofol ............................................................. 35 Provera .............................................................. 36 Provive 1%......................................................... 35 R Ranbaxy Amoxicillin ........................................... 30 Resource Plus.................................................... 33 Resource Thicken Up ......................................... 33 Retrovir .............................................................. 38 ReVia ................................................................. 22 Ridal ............................................................ 26, 35 Risperidone.................................................. 26, 35 S Sodium fluoride .................................................. 23 Staphlex ............................................................. 29 Sumagran .......................................................... 30 Sumatriptan ....................................................... 30 Sunscreens, proprietary ..................................... 30 T Tazocin EF ......................................................... 37 Teniposide ......................................................... 30 Tenoxicam ......................................................... 36 Testosterone undecanoate............................ 19, 36 Topiramate......................................................... 38 Tramadol hydrochloride................................ 19, 35 Tranexamic acid ................................................. 38 Trifeme .............................................................. 32 V Vincristine sulphate ................................ 26, 28, 35 Vinorelbine ......................................................... 24 Vinorelbine Ebewe .............................................. 24

Index

Pharmaceuticals and brands Volibris .............................................................. Voltaren SR ........................................................ Vumon ............................................................... W Wool fat with mineral oil ..................................... Z Zidovudine (AZT) ................................................ Zincaps .............................................................. Zinc sulphate...................................................... 36 29 30 30 38 24 24

Metadata

Title

Schedule Update - effective 1 June 2010

Abstract

Contents Summary of PHARMAC decisions effective 1 June 2010 ….. 3 Exceptional Circumstances prescription claiming … 4 Tramadol hydrochloride – new listing ….. 5 Mitomycin C 5 mg injection – new listing ….. 5 Deca-Durabolin Orgaject – new listing ….…

Page 1

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.